Analysts provide stock recommendations for Cigna Group (CI)

Cigna Group (NYSE: CI) closed the day trading at $282.56 up 0.11% from the previous closing price of $282.24. In other words, the price has increased by $+0.32 from its previous closing price. On the day, 1510373 shares were traded. CI stock price reached its highest trading level at $282.97 during the session, while it also had its lowest trading level at $277.06.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.



For a better understanding of CI, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.61.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 29 when Ryan Cynthia sold 3,768 shares for $282.22 per share. The transaction valued at 1,063,405 led to the insider holds 5,503 shares of the business.

Jones Nicole S sold 7,819 shares of CI for $2,164,768 on Aug 21. The EVP, General Counsel now owns 30,069 shares after completing the transaction at $276.86 per share. On Aug 08, another insider, Agoglia Hoeltzel Mary T, who serves as the SVP Tax & Chief Acct. Officer of the company, sold 12,250 shares for $291.00 each. As a result, the insider received 3,564,750 and left with 2,093 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 82.68B and an Enterprise Value of 105.33B. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.94, and their Forward P/E ratio for the next fiscal year is 10.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 1.81. Its current Enterprise Value per Revenue stands at 0.55.

Stock Price History:

Over the past 52 weeks, CI has reached a high of $340.11, while it has fallen to a 52-week low of $240.50. The 50-Day Moving Average of the stock is 294.98, while the 200-Day Moving Average is calculated to be 279.01.

Shares Statistics:

Over the past 3-months, CI traded about 1.39M shares per day on average, while over the past 10 days, CI traded about 1.95M shares per day. A total of 298.68M shares are outstanding, with a floating share count of 287.17M. Insiders hold about 1.86% of the company’s shares, while institutions hold 88.81% stake in the company. Shares short for CI as of Oct 30, 2023 were 3.35M with a Short Ratio of 3.35M, compared to 2.84M on Sep 28, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.15% and a Short% of Float of 1.15%.

Dividends & Splits

CI’s forward annual dividend rate is 3.93, up from 4.81 a year ago. Against a Trailing Annual Dividend Yield of 1.70%, it implies a Forward Annual Dividend Yield of 1.74%. The stock’s 5-year Average Dividend Yield is 0.76. The current Payout Ratio is 21.03% for CI, which recently paid a dividend on Dec 20, 2023 with an ex-dividend date of Dec 04, 2023. Stock splits for the company last occurred on Jun 04, 2007 when the company split stock in a 3:1 ratio.

Earnings Estimates

Current recommendations for the stock of the company come from 18 analysts. On average, analysts expect EPS of $6.54 for the current quarter, with a high estimate of $6.69 and a low estimate of $6.45, while EPS last year was $4.96. The consensus estimate for the next quarter is $6.35, with high estimates of $6.92 and low estimates of $5.99.

Analysts are recommending an EPS of between $25 and $24.75 for the fiscal current year, implying an average EPS of $24.83. EPS for the following year is $28.21, with 19 analysts recommending between $28.47 and $28.

Revenue Estimates

15 analysts predict $48.9B in revenue for the current quarter. It ranges from a high estimate of $49.68B to a low estimate of $47.92B. As of the current estimate, Cigna Group’s year-ago sales were $45.74B, an estimated increase of 6.90% from the year-ago figure. For the next quarter, 14 analysts are estimating revenue of $55.47B, an increase of 19.30% over than the figure of $6.90% in the same quarter last year. There is a high estimate of $56.82B for the next quarter, whereas the lowest estimate is $52.95B.

A total of 17 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $193.83B, while the lowest revenue estimate was $192.1B, resulting in an average revenue estimate of $192.96B. In the same quarter a year ago, actual revenue was $180.64B, up 6.80% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $229.53B in the next fiscal year. The high estimate is $235.16B and the low estimate is $224.52B. The average revenue growth estimate for next year is up 19.00% from the average revenue estimate for this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular